Novartis, Anumana Partner on AI Cardiovascular Disease Screening Tool Development

In a bid to get in on the preventative side of the cardiovascular disease treatment space, in which it has already risen to become a top name, Novartis has inked a new partnership deal to develop AI-based software for early detection of hidden cardiovascular conditions. The other half of the team-up is Cambridge, Massachusetts-based Anumana...